These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 27519596)

  • 1. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
    Plachter B
    Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-Derived Neutralizing Antibodies to the Human Cytomegalovirus gH/gL Pentamer Potently Block Primary Cytotrophoblast Infection.
    Chiuppesi F; Wussow F; Johnson E; Bian C; Zhuo M; Rajakumar A; Barry PA; Britt WJ; Chakraborty R; Diamond DJ
    J Virol; 2015 Dec; 89(23):11884-98. PubMed ID: 26378171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting viral natural history for vaccine development.
    Barry PA
    Med Microbiol Immunol; 2015 Jun; 204(3):255-62. PubMed ID: 25794555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
    Permar SR; Schleiss MR; Plotkin SA
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
    Fu TM; An Z; Wang D
    Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
    Gerna G; Lilleri D
    New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel vaccines against human cytomegalovirus.
    Cui X; Snapper CM
    Hum Vaccin Immunother; 2019; 15(11):2673-2683. PubMed ID: 31017831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.
    Nelson CS; Vera Cruz D; Su M; Xie G; Vandergrift N; Pass RF; Forman M; Diener-West M; Koelle K; Arav-Boger R; Permar SR
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30518646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
    Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A replication-defective human cytomegalovirus vaccine for prevention of congenital infection.
    Wang D; Freed DC; He X; Li F; Tang A; Cox KS; Dubey SA; Cole S; Medi MB; Liu Y; Xu J; Zhang ZQ; Finnefrock AC; Song L; Espeseth AS; Shiver JW; Casimiro DR; Fu TM
    Sci Transl Med; 2016 Oct; 8(362):362ra145. PubMed ID: 27797961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
    Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
    J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
    Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
    Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.
    Lilleri D; Gerna G
    Rev Med Virol; 2017 Mar; 27(2):. PubMed ID: 28008685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Live Olfactory Mouse Cytomegalovirus Vaccine, Attenuated for Systemic Spread, Protects against Superinfection.
    Farrell HE; Bruce K; Stevenson PG
    J Virol; 2021 Oct; 95(21):e0126421. PubMed ID: 34431701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Vaccines: Current Status and Future Prospects.
    Anderholm KM; Bierle CJ; Schleiss MR
    Drugs; 2016 Nov; 76(17):1625-1645. PubMed ID: 27882457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.